Procurement Summary
Country : USA
Summary : Artificial Intelligence In Pre-Clinical Drug Development For Ad/Adrd (R01 Clinical Trial Not Allowed)
Deadline : 13 Feb 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 111071225
Document Ref. No. : RFA-AG-24-049
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : USD 1000000
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
This Nofo Invites Applications That Apply Existing Or Newly Developed Artificial Intelligence And Machine Learning Methods (Ai/Ml) To Various Aspects Of Drug Discovery And Preclinical Drug Development To Accelerate The Identification, Optimization, And Selection Of Preclinical Drug Candidates For The Treatment And Prevention Of Alzheimers Disease (Ad) And Ad-Related Dementias Adrd And Increase Their Likelihood Of Success During Clinical Drug Development.This Program Will Also Create Advanced Open-Source Analytical Tools That Will Be Made Available To Researchers In Academia And Biotech/Pharma For More Effective Prosecution Of Ad/Adrd Drug Discovery Campaigns For Novel Targets.
Opportunity Category : Discretionary
Opportunity Category Explanation :
Funding Instrument Type : Grant
Category of Funding Activity : Health
CFDA_Number :
Award_Ceiling : 1000000
Posted Date : Dec 02, 2024
Last Updated Date : Dec 02, 2024
Documents
Tender Notice